Advanced Search

 

Study ID Status Title Patient Level Data
29060/356_1 Completed Extension phase for a double-blind, multicentre study to compare paroxetine and fluoxetine in the treatment of patients with major depressive disorder with regard to antidepressant efficacy, effects on associated anxiety and tolerability.
29060/358 Completed Comparative study of paroxetine and mianserin in depression of the elderly: efficacy, tolerance, serotonin dependence.
29060/360 Completed A single dose, crossover study to determine the comparative bioavailability of an oral liquid preparation of paroxetine (30 mg pfb) and a 30 mg pfb paroxetine tablet
29060/368 Completed Belgian Paroxetine Experience: An open-label study evaluating the efficacy and safety of paroxetine in depressed patients treated by Belgian psychiatrists and general practitioners
29060/374 Completed A repeat-dose steady-state crossover evaluation of the bioequivalence of a 20 mg “wet granulation” standard Paxil™ tablet with a liquid formulation of paroxetine (20 mg p.f.b)
29060/377 Completed A Double-blind, Multicentre Placebo-Controlled Study of Paroxetine in Adolescents with Unipolar Major Depression. Study Listed on ClinicalStudyDataRequest.com
29060/382 Completed A Randomized, Double-Blind, Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Phobia Study Listed on ClinicalStudyDataRequest.com
29060/391 Completed A double-blind study of the effects of paroxetine, fluoxetine and placebo on driving ability in healthy volunteers
29060/395 Completed Double-blind, randomised study to compare the effects of paroxetine and amitriptyline on driving ability and psychomotor performance in patients with mild to moderate depression treated for at least 4 weeks
29060/397 Completed A double-blind multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in general practice
29060/398 Completed Pharmacokinetics of paroxetine 10 mg, 20 mg and 40 mg in single oral administration in healthy volunteers
29060/400 Completed A Double-Blind, Placebo Controlled Study to Investigate the Efficacy, Safety and Tolerability of Paroxetine in Patients with Premenstrual Dysphoric Disorder.
29060/402 Completed A double-blind, multicentre, parallel group study of paroxetine and amitriptyline in the treatment of patients with depression associated with breast cancer
29060/403 Completed Antidepressant efficacy and safety of paroxetine; a double blind amitriptyline controlled multicenter comparison study in depressive patients.
29060/406 Completed A Double-Blind, Long-Term Extension Study for Patients Previously Participating in Protocol 29060/131
29060/409 Completed A comparative, controlled double blind, double dummy study about the efficacy and safety of paroxetine vs imipramine in ambulatory patients with major depression
29060/418 Completed A single-dose 3-part crossover study to determine the comparative bioavailability of two oral liquid preparations of paroxetine (30 mg pfb) and a 30 mg tablet of paroxetine
29060/419 Completed A repeat-dose steady-state crossover evaluation of the bioequivalence of a 20 mg direct compression tablet of paroxetine with a 20 mg standard “Paxil” tablet
29060/421 Completed Paroxetine and Fluoxetine effects on mood and cognitive function in depressed nondemented elderly patients. Extensive searching has revealed that no clinical report is available for this study. The clinical trial results were reported via publications; see citation below.
29060/427 Completed A Multicentre, Double-Blind, Placebo-Controlled Study to Investigate the Effects of Paroxetine (5mg OD Vs 10mg OD Vs 20mg OD) in Patients with Premenstrual Dysphoric Disorder (PMDD).
29060/433 Completed Treatment of fibromyalgia: a randomized, double-blind, placebo-controlled study of paroxetine, a selective serotonin re-uptake inhibitor
29060/436 Completed Safety Evaluation of Paroxetine in Elderly Depressed Patients
29060/437 Completed A Double-blind, Placebo-controlled Study to Investigate the Effect of Pindolol on the Onset of Anti-depressant Activity of Paroxetine in the Treatment of Depression.
29060/440 Completed A single dose 4-part crossover study to determine the comparative bioavailability of an oral liquid formulation of paroxetine (20 mg pfb) and a standard 20 mg pfb Paxil tablet administered immediately before and after breakfast
29060/442 Completed A multicentre, randomised, double-blind study to compare paroxetine versus placebo in the treatment of double depression.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.